Cleansing Efficacy of Cosmetic Product

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-08

Study Completion Date

2025-05-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the cleansing effect of one cosmetic product containing Mitopure against a particular matter model pollutant in comparison to an untreated control.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Emulsion 8-Week Anti-acne Efficacy Clinical Study

NCT06985745

Female Male Acne

ACTIVE_NOT_RECRUITING NA

Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure

NCT06796010

Visible Light Exposure Healthy Back Skin

COMPLETED

Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT Study

NCT04355286

Absorption; Chemicals Sunscreening Agents

COMPLETED PHASE1

Cutaneous Acceptability, Comedogenic Potential and Efficacy of Two Cosmetic Products Used in Synergy

NCT05490537

Acne

COMPLETED

Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers

NCT01254162

Oily Skin Seborrhea

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Skin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two test areas will be defined on both forearms. Area 1 will be located on the right forearm; Area 2 will be located on the left forearm. Treatments will be randomly and balanced assigned to the test areas.

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cosmetic product

Test area topically washed with cleanser containing Mitopure

Group Type EXPERIMENTAL

Topical cosmetic cleanser

Intervention Type OTHER

After applying the model pollutant, the test area will be topically cleaned with the active cosmetic cleanser with Mitopure.

Tap water (control)

Test area topically washed with tap water

Group Type OTHER

Topical tap water

Intervention Type OTHER

After applying the model pollutant, the test area will be topically cleaned with tap water (control).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topical cosmetic cleanser

After applying the model pollutant, the test area will be topically cleaned with the active cosmetic cleanser with Mitopure.

Intervention Type OTHER

Topical tap water

After applying the model pollutant, the test area will be topically cleaned with tap water (control).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent to participate in the study
* Willingness to actively participate in the study and to come to the scheduled visits
* Female and/or male
* From 18 to 70 years of age
* Healthy skin in the test area
* Skin type on Fitzpatrick scale: I, II or III

Exclusion Criteria

* Female subjects: Pregnancy or lactation
* Drug addicts, alcoholics
* AIDS, HIV-positive or infectious hepatitis
* Conditions which exclude a participation or might influence the test reaction/evaluation
* Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
* Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
* Active skin disease at the test area
* Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
* Any topical medication at the test area within the last 4 weeks prior to the start of the study and during the study
* Documented allergies to cosmetic products and/or ingredients

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes